Embecta Corp (EMBC)
13.13
+0.14
(+1.08%)
USD |
NASDAQ |
May 24, 16:00
13.14
+0.01
(+0.08%)
After-Hours: 20:00
Embecta Profit Margin (Quarterly): 10.06% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.06% |
| December 31, 2023 | 7.25% |
| September 30, 2023 | 2.13% |
| June 30, 2023 | 5.31% |
| March 31, 2023 | 5.05% |
| December 31, 2022 | 12.77% |
| September 30, 2022 | -6.26% |
| Date | Value |
|---|---|
| June 30, 2022 | 21.44% |
| March 31, 2022 | 29.00% |
| December 31, 2021 | 34.15% |
| September 30, 2021 | 32.21% |
| June 30, 2021 | 35.49% |
| March 31, 2021 | 37.97% |
| December 31, 2020 | 36.91% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.26%
Minimum
Sep 2022
37.97%
Maximum
Mar 2021
18.82%
Average
17.10%
Median
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -14.54K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -122.6% |
| Electromed Inc | 10.76% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 5.76% |
| Return on Invested Capital | 8.77% |
| Gross Profit Margin (Quarterly) | 64.55% |
| Operating Margin (Quarterly) | 13.65% |
| Return on Net Operating Assets | 10.65% |